AORT Artivion, Inc.

NYSE
$29.14

Artivion, Inc. (AORT) is expected to report earnings on November 5, 2026, after the market close. The consensus earnings estimate is $0.11 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +8.3% since its last earnings release on August 6, 2026.

Artivion Reported In-line with Estimates, Reaffirms
Thursday, August 6, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 5
Thursday · 4:05 PM ET
Earnings Whisper
-
vs $0.11
Rev est $121.8M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $27.98

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Artivion, Inc.

Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases.

Sector

Healthcare

Industry

Medical Instruments/Supply